Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Traeger Inc. (COOK) PT Raised to $5 at Canaccord Genuity
-
Traeger to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Canaccord Genuity Downgrades Progyny (PGNY) to Hold
-
Touchstone Exploration Inc. Announces Employee Share Purchase Plan
-
Travere Therapeutics to Present at Upcoming Investor Conferences
-
Pliant Therapeutics to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference
-
Standard BioTools to Participate in Upcoming Investor Conferences
-
Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference
-
Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Converge Technology Solutions Announces Participation in the Canaccord Genuity 44th Annual Growth Conference
-
SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024
-
NervGen Pharma to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Clover Health (CLOV) PT Raised to $2.50 at Canaccord Genuity
-
Canaccord Genuity Downgrades TELUS Corp. (T:CN) (TU) to Hold
-
Sportradar to Participate in Canaccord Genuity 44th Annual Growth Conference
-
Merus to Present at Canaccord Genuity’s 44th Annual Growth Conference
-
Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
-
Regulus Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 05 08 2024] - (CGWL)
-
Kiora Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Passage Bio to Participate in Upcoming Investor Conferences
-
Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference
-
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
-
Artivion to Participate in Upcoming Investor Conferences
-
Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance
-
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Participation in Upcoming Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
ChromaDex to Present at Canaccord Genuity’s 44th Annual Growth Conference
-
Lucid Diagnostics to Participate in Upcoming Investor Conferences
-
Bridger Aerospace Announces Schedule for its Second Quarter 2024 Earnings Release and Conference Call
-
Clene to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
-
Touchstone Exploration Inc. Announces Statement Regarding Lease Operators Offer
-
EuroPacific Closes First Tranche of Private Placement
-
Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference
-
Pega to Present at Upcoming Investor Conference
-
Aurora Announces Closing of $483 Million Upsized Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Driven Brands (DRVN) PT Raised to $19 at Canaccord Genuity
-
Compass Pathways (CMPS) PT Lowered to $48 at Canaccord Genuity
-
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Alnylam Pharmaceuticals (ALNY) PT Raised to $366 at Canaccord Genuity
-
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity's 44th Annual Growth Conference
-
ACI Worldwide (ACIW) PT Raised to $60 at Canaccord Genuity
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 01 08 2024] - (CGWL)
-
Valeura Energy Inc. Announces Wassana Production Restart
-
Trupanion to Participate in the Canaccord Genuity 44th Annual Growth Conference
-
Pulse Biosciences, Inc. Announces Participation in Upcoming Investor Conferences
-
T2 Biosystems to Attend Upcoming Investor Conferences
-
Arcturus Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference
-
Adicet Bio to Participate in Upcoming Investor Conferences
-
Rupert Resources Closes $28.8 Million Equity Financing

